Luye Pharma Group Ltd (LUP) — Cash Flow-to-Debt Ratio
Luye Pharma Group Ltd (LUP) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €344.86 Million could theoretically repay 0% of its total liabilities (€14.11 Billion) in one year. See free cash flow generation of Luye Pharma Group Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Luye Pharma Group Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Luye Pharma Group Ltd across 10 annual periods. Also explore LUP shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Luye Pharma Group Ltd (2016–2025)
Year-by-year debt coverage analysis for Luye Pharma Group Ltd. For market capitalisation and broader financial context, see Luye Pharma Group Ltd (LUP) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | €1.78 Billion | €14.47 Billion | ▲ +918.2% |
| 2024 | 0.01x | €167.76 Million | €13.86 Billion | ▼ -90.9% |
| 2023 | 0.13x | €1.60 Billion | €11.96 Billion | ▲ +6.5% |
| 2022 | 0.13x | €1.65 Billion | €13.21 Billion | ▲ +824.7% |
| 2021 | 0.01x | €182.37 Million | €13.47 Billion | ▼ -83.6% |
| 2020 | 0.08x | €1.03 Billion | €12.53 Billion | ▼ -42.4% |
| 2019 | 0.14x | €1.42 Billion | €9.94 Billion | ▲ +31.4% |
| 2018 | 0.11x | €1.05 Billion | €9.60 Billion | ▼ -56.4% |
| 2017 | 0.25x | €964.10 Million | €3.86 Billion | ▲ +11.4% |
| 2016 | 0.22x | €592.03 Million | €2.64 Billion | — |